Stable angina
Searched over 200M research papers for "stable angina"
Summary
10 papers analyzed
These studies suggest that stable angina is caused by coronary artery disease and managed through medications, lifestyle changes, and revascularization, with a focus on symptom relief, preventing disease progression, and reducing complications.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Understanding Stable Angina: Diagnosis, Management, and Treatment
What is Stable Angina?
Stable angina is a type of chest pain or discomfort due to coronary artery disease. It is termed "stable" because it follows a predictable pattern, typically triggered by physical exertion or stress and relieved by rest or medication such as nitrates. The underlying cause is usually atherosclerosis, where fatty deposits build up in the coronary arteries, narrowing them and limiting blood flow to the heart muscle.
Diagnosis of Stable Angina
Diagnosing stable angina involves recognizing the characteristic symptoms of chest pain on exertion that is relieved by rest or nitrates. Non-invasive tests like exercise tolerance testing, echocardiography, and coronary angiography are crucial for confirming the diagnosis and assessing the severity of the disease . These tests help in risk stratification, which is essential for determining the appropriate treatment strategy.
Risk Stratification and Prognosis
Risk stratification is vital in managing stable angina, as it helps predict the likelihood of acute coronary events such as myocardial infarction (MI) or death. Factors like prior MI, left ventricular hypertrophy, and increased left ventricular dimensions on echocardiogram are associated with higher risks. The prognosis of stable angina varies, with a 10-year survival rate of 58% for men and 68% for women, influenced by factors such as age, sex, and the extent of coronary artery disease.
Treatment Strategies for Stable Angina
Medical Management
The primary goals in treating stable angina are to alleviate symptoms, improve quality of life, and prevent disease progression and complications like MI or heart failure. Key components of medical management include:
- Antianginal Medications: These include beta-blockers, calcium channel blockers, nitrates, and newer agents like nicorandil, trimetazidine, and ranolazine . Beta-blockers are often the first line of treatment, reducing the incidence of cardiac events and improving survival, especially post-MI. Calcium channel blockers and nitrates are alternatives or adjuncts, particularly when beta-blockers are contraindicated or not tolerated.
- Secondary Prevention: This involves the use of antiplatelet agents (e.g., aspirin), statins, and possibly ACE inhibitors to manage risk factors for atherosclerosis and prevent further cardiovascular events .
- Lifestyle Modifications: Patients are advised to adopt healthy lifestyle changes, including smoking cessation, regular physical activity, and a heart-healthy diet.
Revascularization
For certain high-risk patients, revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) may be necessary. These procedures can significantly improve symptoms and prognosis, especially in patients with severe coronary artery disease or those who do not respond adequately to medical therapy .
Conclusion
Stable angina is a common manifestation of coronary artery disease, characterized by predictable chest pain due to exertion. Effective management involves a combination of medical therapy, lifestyle changes, and possibly revascularization, aimed at symptom relief, improving quality of life, and preventing serious cardiovascular events. Accurate diagnosis and risk stratification are essential to tailor the treatment approach to individual patient needs.
Sources and full results
Most relevant research papers on this topic
6
Unstable Angina A Classification
6
1,386 Citations
1989